PeptideTrace
Clinical

New clinical trial registered for Semaglutide

Related compound: SemaglutideView source →

Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults (NCT07513168) registered on ClinicalTrials.gov. Phase: phase 4. Status: recruiting.